Business Description
Stella Pharma Corp
ISIN : JP3399680002
Share Class Description:
TSE:4888: Ordinary SharesDescription
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.4 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -1.12 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 5.64 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.4 | |||||
| 3-Year EBITDA Growth Rate | 9 | |||||
| 3-Year EPS without NRI Growth Rate | 9.2 | |||||
| 3-Year FCF Growth Rate | 10.3 | |||||
| 3-Year Book Growth Rate | 108.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.15 | |||||
| 9-Day RSI | 62.84 | |||||
| 14-Day RSI | 57.2 | |||||
| 6-1 Month Momentum % | 27.35 | |||||
| 12-1 Month Momentum % | 51.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.82 | |||||
| Quick Ratio | 17.82 | |||||
| Cash Ratio | 17.08 | |||||
| Days Inventory | 7280.76 | |||||
| Days Sales Outstanding | 117.58 | |||||
| Days Payable | 436.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.3 | |||||
| Shareholder Yield % | 0.87 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.63 | |||||
| Operating Margin % | -282.12 | |||||
| Net Margin % | -283.4 | |||||
| FCF Margin % | -329.44 | |||||
| ROE % | -27.87 | |||||
| ROA % | -17.87 | |||||
| ROIC % | -56.36 | |||||
| ROC (Joel Greenblatt) % | -66.11 | |||||
| ROCE % | -19.02 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 59.67 | |||||
| PB Ratio | 5.72 | |||||
| Price-to-Tangible-Book | 5.8 | |||||
| EV-to-EBIT | -19.42 | |||||
| EV-to-EBITDA | -19.42 | |||||
| EV-to-Revenue | 54.66 | |||||
| EV-to-FCF | -16.48 | |||||
| Price-to-Net-Current-Asset-Value | 6.08 | |||||
| Price-to-Net-Cash | 10.79 | |||||
| Earnings Yield (Greenblatt) % | -5.15 | |||||
| FCF Yield % | -5.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stella Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 269.491 | ||
| EPS (TTM) (円) | -24.663 | ||
| Beta | 1.23 | ||
| Volatility % | 35.78 | ||
| 14-Day RSI | 57.2 | ||
| 14-Day ATR (円) | 16.940643 | ||
| 20-Day SMA (円) | 496.15 | ||
| 12-1 Month Momentum % | 51.15 | ||
| 52-Week Range (円) | 229 - 602 | ||
| Shares Outstanding (Mil) | 34.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stella Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stella Pharma Corp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stella Pharma Corp Frequently Asked Questions
What is Stella Pharma Corp(TSE:4888)'s stock price today?
The current price of TSE:4888 is 円516.00. The 52 week high of TSE:4888 is 円602.00 and 52 week low is 円229.00.
When is next earnings date of Stella Pharma Corp(TSE:4888)?
The next earnings date of Stella Pharma Corp(TSE:4888) is .
Does Stella Pharma Corp(TSE:4888) pay dividends? If so, how much?
Stella Pharma Corp(TSE:4888) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers